TONYA TEASLEY: Open Payments
NPI 1821683186 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,792 in 110 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,792
Food & beverage: $1,792
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $282 |
| Neurocrine BioSciences, Inc. | 15 | $194 |
| Otsuka America Pharmaceutical, Inc. | 10 | $172 |
| ABBVIE INC. | 16 | $167 |
| Lundbeck LLC | 8 | $165 |
| Alkermes, Inc. | 6 | $151 |
| Teva Pharmaceuticals USA, Inc. | 10 | $142 |
| Axsome Therapeutics, Inc. | 8 | $141 |
| Janssen Pharmaceuticals, Inc | 5 | $98 |
| Vanda Pharmaceuticals Inc. | 5 | $78 |
Products named: REXULTI, CAPLYTA, INGREZZA, VRAYLAR, ARISTADA, HETLIOZ, AUSTEDO XR, Auvelity.
Industry payments across SC — which companies pay providers there.
